Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. 1995

S Schreiber, and T Heinig, and U Panzer, and R Reinking, and A Bouchard, and P D Stahl, and A Raedler
Department of Medicine, University of Hamburg, Germany.

OBJECTIVE In inflammatory bowel disease (IBD), peripheral monocytes and intestinal macrophages show an increased state of priming and activation. The aim of this study was to test the hypothesis that the response of IBD mononuclear phagocytes to the contrainflammatory cytokine interleukin (IL) 4 may be altered. METHODS The in vitro secretion of proinflammatory cytokines (IL-1 beta, tumor necrosis factor alpha [TNF-alpha], and IL-1-receptor antagonist [IL-1ra]) by peripheral monocytes and by intestinal lamina propria mononuclear cells (LPMNCs) was assessed by enzyme-linked immunosorbent assay. In parallel, superoxide anion release, macrophage mannose receptor, and IL-4 receptor expression were investigated. RESULTS IBD peripheral monocytes and intestinal LPMNCs in vitro secrete increased amounts of proinflammatory cytokines (IL-1 beta and TNF-alpha) with decreased IL-1ra/IL-1 beta ratios. IL-4 down-regulates proinflammatory cytokine (IL-1 beta and TNF-alpha) and superoxide anion secretion in a dose-dependent manner. In contrast to normal and disease-specific controls, IBD peripheral monocytes and IBD intestinal LPMNCs show a diminished responsiveness to the inhibitory effect of IL-4. The IL-1ra/IL-1 beta ratios in normal monocytes are increased by IL-4, whereas in IBD monocytes low IL-1ra/IL-1 beta ratios persist after IL-4 treatment. IL-4-induced expression of macrophage mannose receptor, which is a molecule pivotal to macrophage-mediated host defense, again appeared to be impaired in IBD monocytes. CONCLUSIONS IL-4-mediated regulation of mononuclear phagocyte effector functions is disturbed in IBD.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010586 Phagocytes Cells that can carry out the process of PHAGOCYTOSIS. Phagocyte,Phagocytic Cell,Phagocytic Cells,Cell, Phagocytic,Cells, Phagocytic
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090323 Mannose Receptor A member of a family of endocytic receptors. Highly expressed on human macrophages, involved in regulating endocytosis, phagocytosis, and immune responses. CD206 Antigen,Cluster of Differentiation 206,MRC1 Protein,Mannose Receptors,Mannose-Fucose Receptor,Mannosyl-Fucosyl Receptor,Receptor, Mannose,206 Cluster, Differentiation,Antigen, CD206,Differentiation 206 Cluster,Mannose Fucose Receptor,Protein, MRC1,Receptor, Mannose-Fucose
D013481 Superoxides Highly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to METHEMOGLOBIN. In living organisms, SUPEROXIDE DISMUTASE protects the cell from the deleterious effects of superoxides. Superoxide Radical,Superoxide,Superoxide Anion
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

S Schreiber, and T Heinig, and U Panzer, and R Reinking, and A Bouchard, and P D Stahl, and A Raedler
January 2020, Frontiers in immunology,
S Schreiber, and T Heinig, and U Panzer, and R Reinking, and A Bouchard, and P D Stahl, and A Raedler
April 1982, Clinical and experimental immunology,
S Schreiber, and T Heinig, and U Panzer, and R Reinking, and A Bouchard, and P D Stahl, and A Raedler
January 1991, Gastroenterology,
S Schreiber, and T Heinig, and U Panzer, and R Reinking, and A Bouchard, and P D Stahl, and A Raedler
January 1995, Gastroenterology,
S Schreiber, and T Heinig, and U Panzer, and R Reinking, and A Bouchard, and P D Stahl, and A Raedler
January 1987, Journal of clinical immunology,
S Schreiber, and T Heinig, and U Panzer, and R Reinking, and A Bouchard, and P D Stahl, and A Raedler
December 1994, The Journal of allergy and clinical immunology,
S Schreiber, and T Heinig, and U Panzer, and R Reinking, and A Bouchard, and P D Stahl, and A Raedler
September 1985, Clinical science (London, England : 1979),
S Schreiber, and T Heinig, and U Panzer, and R Reinking, and A Bouchard, and P D Stahl, and A Raedler
September 1996, Digestive diseases and sciences,
S Schreiber, and T Heinig, and U Panzer, and R Reinking, and A Bouchard, and P D Stahl, and A Raedler
January 2005, Journal of clinical gastroenterology,
S Schreiber, and T Heinig, and U Panzer, and R Reinking, and A Bouchard, and P D Stahl, and A Raedler
June 1996, Gastroenterology,
Copied contents to your clipboard!